Anzeige
Erschienen in:
29.02.2020 | Original Research
Tumor Microenvironment Mediators CD8+- and FOXP3+-Labeled T Lymphocytes Are Prospective Prognosticators in Curatively Treated Rectal Cancer Patients
Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 1/2021
Einloggen, um Zugang zu erhaltenAbstract
Purpose
To explore the implication of CD8+- and FOXP3+-labeled T lymphocytes invading tumor microenvironment in prognosticating curatively treated rectal cancer with preoperative chemo-radiation.
Methods
The diagnostic rectal biopsies from clinical T3–T4 and any nodal diseases or any T stage with nodal involvement were processed to quantify (CD8+and FOXP3+). The impact of tested indicators on the achieved pathologic response among other clinical-pathological variables was particularized. Additionally, the prognosticating eventuality of labeled T lymphocytes for survival was elaborated using Log-rank and Cox regression.
Results
We selected fifty rectal patients who had negative surgical margins following preoperative chemo-radiation for clinical T3–T4 or any T stage with nodal involvement. The higher expressions of CD8+ and CD8+/FOXP3+, and the reduced FOXP3+incursion were interrelated with the lack of nodal and lympho-vascular invasion alongside accentuated pathologic response. Additionally, the augmented densities of FOXP3+ ≥ 120, the reduced CD8+/FOXP3+ ratio < 0.96, and the nodal incursion were considerably linked with the worsened OS [hazard ratio (HR) 2.37 (95% confidence interval (CI), 2.38–11.27), 2.41 (95% CI, 2.14–7.12), and 2.63 (95% CI, 2.81–5.32)], and dismal DFS [HR 2.61 (95% CI, 1.58–6.12), 3.12 (95% CI, 2.15–7.24), and 3.32 (95% CI, 2.47–9.24)], respectively.
Conclusion
The augmented expressions of CD8+ and C8+/FOXP3+ together with the reduced densities of FOXP3+ exhibited a substantial contribution to the attained pathological response and were linked to improved clinical-pathological characteristics of cancer rectum patients treated with chemo-radiation preceding mesorectal excision. Additionally, they can be authorized as reliable individual prognosticators of clinical outcomes.